Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Stable Gastric Pentadecapeptide BPC 157 in Trials for Inflammatory Bowel Disease (PL-10, PLD-116, PL 14736, Pliva, Croatia)
From its discovery in Zagreb as a fragment of gastric protective protein to over 100 published studies examining its diverse applications, the scientific foundation for BPC-157 is more substantial than most other research peptides
A prospective study involving individuals initiated on semaglutide, evaluated via ultrasound after an overnight fast, demonstrated that 70% of those receiving semaglutide exhibited retained solid gastric content, in contrast to 10% in the control group [17]
The synergistic effects of these peptides may offer Latvia individuals a comprehensive approach to supporting fat metabolism, potentially leading to improved body composition and overall physical performance (3)
US$ 21.07
US$ 24.74
US$ 22.94
US$ 22.52
